Watchlist
Loading...
US Stock MarketDetailed Quotes

BNTX BioNTech

Watchlist
99.400 -1.010-1.01% Close 12/01 16:00 ET
99.430+0.030+0.03% Pre 08:46 ET
99.640High94.700Low802.92KVolume
Pre-Market
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

About BioNTech Company

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Revenue Breakdown

Business Currency:EUR
2022/12/31
Stock NameRevenueRatio
Share of collaboration partners gross profit12.74B73.57%
Direct product sales to customers3.18B18.40%
Sales to collaboration partners1.22B7.07%
Research & development revenues from collaborations116M0.67%
Other sales49.4M0.29%

Comments

Read more
Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >